Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Single-arm Extension Study to Characterize the Long-term Safety of Cinacalcet Hydrochloride in the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects With Chronic Kidney Disease on Dialysis

NCT02341417 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02341417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02341417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Single-arm Extension Study to Characterize the Long-term Safety of Cinacalcet Hydrochloride in the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects With Chronic Kidney Disease on Dialysis
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
June 10, 2015
Completion date
March 15, 2017
Enrollment
28 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

secondary hyperparathyroidism, chronic kidney disease